About Tempus, Inc.
Tempus, Inc. is a leading technology company that has revolutionized the healthcare industry by building the world's largest library of clinical and molecular data. The company has developed an operating system that makes this data accessible and useful, with a focus on cancer research.
Founded in 2015 by Eric Lefkofsky, Tempus has quickly become a leader in the field of precision medicine. The company's mission is to improve patient outcomes by providing physicians with real-time insights into their patients' conditions and personalized treatment options.
One of Tempus' key strengths is its ability to collect and analyze vast amounts of data from various sources. The company has partnerships with over 100 hospitals and academic institutions across the United States, allowing it to access millions of patient records.
Tempus' operating system uses advanced machine learning algorithms to identify patterns in this data that can help physicians make more informed decisions about their patients' care. For example, if a patient's tumor has a specific genetic mutation, Tempus can recommend treatments that have been shown to be effective for other patients with similar mutations.
In addition to its work in cancer research, Tempus is also exploring applications for its technology in other areas of healthcare. For example, the company recently announced a partnership with AstraZeneca to develop personalized treatments for cardiovascular disease.
Overall, Tempus is at the forefront of an exciting new era in healthcare where data-driven insights are transforming how we diagnose and treat diseases. With its world-class team of scientists and engineers, cutting-edge technology platform, and commitment to improving patient outcomes, it's no wonder why so many people are excited about what this innovative company will achieve next!